Table 1 – Patient characteristics: (a) baseline clinical outcomes; (b) tumor characteristics.
(a) (a) (a) (a) (a) (a) (a) (a) (a)
Total (n = 19) Responders (n = 12)
Non-responders (n = 7)
P value
Age (years) (mean ± SD) 56.1 ± 10.5 52.2 ± 10.5 51.42 ± 10.6 0.098
Gender, n Female Male 6 13 4 8 2 5
0.622
Complaint Hematuria LUTS Flank pain 10 5 4 6 2 4 4 3 0
0.171
Smoking, n Yes No 14 5 8 4 6 1
0.603
Occupational risk, n Yes No 4 15 2 10 2 5
0.475
Familial cancer history, n Yes No 7 12 4 8 3 4
0.526
(b) (b) (b) (b) (b) (b) (b) (b) (b)
Tumor stage T1 Ta 5 14 1 11 4 3
0.508
Tumor size <3 cm ≥3 cm 10 9 7 5 3 4
0.650
Number of tumors Single Multiple 12 7 9 3 3 4
0.603
Tumor morphology Papillary Non-papillary 16 3 11 1 5 2
0.359
Additional treatment, n Maintenance BCG Radical cystectomy 18 1 12 0 6 1
0.249
SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin SD = standard deviation; LUTS = lower urinary tract symptoms; BCG = Bacillus Calmette-Guérin